The present study was undertaken to gain insights into the molecular mechanism of cell death (apoptosis) by guggulsterone, a constituent of Ayurvedic medicinal plant Commiphora mukul, using PC-3 human prostate cancer cells as a model.
Introduction
Prostate cancer is the second leading cause of cancerrelated deaths among men in the United States (1) . Prostate carcinogenesis is a multistep process involving progression from localized, low-grade lesions to large, high-grade, metastatic carcinomas. Molecular mechanism underlying onset or progression of prostate cancer is not fully defined, but age, race, diet, and androgen secretion and metabolism are the identifiable risk factors associated with this malignancy (2, 3) . Therapeutic options exist for localized disease, which include surgery, radiation therapy, and hormonal therapy. Androgen ablation is a frequently prescribed treatment option for prostate cancer (4) . This treatment modality, however, is palliative and has limited scope, especially for hormone-refractory cancers (4) . Moreover, chemotherapy and radiation therapy are largely ineffective against advanced prostate cancer (5, 6). Prostate cancer is usually diagnosed in the sixth or seventh decades of life, which allows a large window of opportunity for intervention to prevent or slow progression of the disease. Therefore, clinical development of agents that are nontoxic to normal cells but can delay onset and/or progression of human prostate cancer could have a significant effect on disease-related cost, morbidity, and mortality for a large segment of population.
Guggulsterone [4,17(20) -(cis)-pregnadiene-3,16-dione; see Fig. 1A for structure of guggulsterone] is a plant sterol derived from the gum resin (guggulu) of the tree Commiphora mukul that has been used extensively in Indian Ayurvedic medicine for the treatment of different ailments, including bone fracture, arthritis, inflammation, cardiovascular disease, and lipid disorders (7 -11) . Recent studies have shown that guggulsterone is an antagonist of bile acid farnesoid X receptor (12, 13) . In addition, guggulsterone regulates cholesterol homeostasis by increasing the transcription of bile salt export pump (14) .
Recently, Shishodia and Aggarwal (15) showed that guggulsterone is a potent suppressor of nuclear factor-nB (NF-nB) activation in tumor cells. NF-nB is a transcription factor belonging to the Rel family of proteins that are involved in regulation of various genes, including inflammatory cytokines, chemokines, cell adhesion molecules, growth factors, and IFNs (16, 17) . NF-nB activation is considered a prosurvival signal because this transcription factor regulates gene expression of several antiapoptotic proteins, including cIAP1, XIAP, Bfl-1/A1, Bcl-2, cFLIP, and survivin (18 -25) . Interestingly, NF-nB is constitutively activated in a variety of hematologic and solid tumor cells, including prostate cancer cells (26 -31) .
Because guggulsterone inhibits NF-nB activation (15), we hypothesized that this phytochemical might inhibit growth of cancer cells by causing cell death. In the present study, we tested this hypothesis using PC-3 human prostate cancer cells as a model. We show that guggulsterone suppresses proliferation of PC-3 human prostate cancer cells, but not a normal prostate epithelial cell line, by causing apoptosis induction in association with induction of multidomain proapoptotic Bcl-2 family members Bax and Bak and down-regulation of antiapoptotic proteins Bcl-2 and Bcl-xL leading to activation of caspases. Selectivity of guggulsterone toward cancer cells is intriguing and warrants its clinical development as a potential chemopreventive or therapeutic agent for prostate cancer.
Materials and Methods
Reagents Z-Guggulsterone was purchased from Steraloids (Newport, RI). Tissue culture medium and fetal bovine serum were from Invitrogen (Grand Island, NY), propidium iodide was from Sigma (St. Louis, MO), and RNase A was from Promega (Madison, WI). Antibodies against Bak (clone G-23), Bax (clone N-20), and Bcl-xL (clone H-5) were from Santa Cruz Biotechnology (Santa Cruz, CA), antibody against caspase-9 was from BD PharMingen (Palo Alto, CA), anticaspase-8 antibody was from Biosource (Camarillo, CA), antibody specific for detection of cleaved caspase-3 was from Cell Signaling Technology (Beverly, MA), antibody against Bcl-2 (clone 124) was from DAKO (Carpinteria, CA), and anti-actin antibody was from Oncogene Research Products (Boston, MA). The caspase inhibitors zVAD-fmk (general caspase inhibitor), zIETD-fmk (caspase-8), and zLEHD-fmk (caspase-9) were from Enzyme Systems (Dublin, CA).
Cell Culture and Cell Survival Assays Monolayer cultures of PC-3 cells were maintained in F-12K nutrient mixture (Kaighn's modification) supplemented with 7% (v/v) non-heat-inactivated fetal bovine serum and antibiotics. Normal prostate epithelial cell line PrEC (Clonetics, San Diego, CA) was maintained in PrEBM (Cambrex, Walkersville, MD). The culture conditions for PC-3/neo and PC-3/Bcl-2 cells have been described by us previously (32, 33) . The PC-3/neo and PC-3/Bcl-2 cells were maintained similarly, except that G418 (500 Ag/mL) was added to the cultures. The mouse embryonic fibroblasts (MEF) derived from wild-type (WT), Bax or Bak single knockout, and Bax-Bak double knockout mice and immortalized by transfection with a plasmid containing SV40 genomic DNA were generously provided by Dr. Stanley J. Korsmeyer (Dana-Farber Cancer Institute, Boston, MA) and maintained as described previously (34) . Each cell line was maintained in an atmosphere of 95% air and 5% CO 2 at 37jC. The effect of guggulsterone on cell viability was determined by sulforhodamine B and trypan blue dye exclusion assays as described previously (32) .
Analysis of Cell Cycle Distribution Effect of guggulsterone treatment on cell cycle distribution was determined by flow cytometry following staining with propidium iodide as described previously (35, 36) . Briefly, cells (5 Â 10 5 ) were seeded in T25 flasks and allowed to attach by overnight incubation. The medium was replaced with fresh complete medium containing desired concentrations of guggulsterone. Stock solution of guggulsterone was prepared in DMSO and diluted with complete medium. An equal volume of DMSO (final concentration, 0.1%) was added to the controls. Following incubation at 37jC for 24 or 48 hours, floating and attached cells were collected, washed with PBS, and fixed with 70% ethanol. Fixed cells were then treated with RNase A and propidium iodide, and the stained cells were analyzed using a Coulter Epics XL flow cytometer (Miami, FL) as described previously (35, 36) . Cells in different phases of the cell cycle were computed for control (DMSO-treated) and guggulsterone-treated cultures.
Detection of Apoptosis Apoptosis induction in guggulsterone-treated cells was assessed by fluorescence microscopic analysis of cells with condensed and segmented DNA following staining with 4V,6-diamidino-2-phenylindole, flow cytometric analysis of cells with sub-G 0 -G 1 DNA content following staining with propidium iodide, or analysis of cytoplasmic histoneassociated DNA fragmentation. For 4V,6-diamidino-2-phenylindole staining, 2 Â 10 4 cells were grown on coverslips and allowed to attach overnight. Cells were then exposed to DMSO (control) or desired concentration of guggulsterone for 24 hours and fixed with 4% paraformaldehyde in PBS for 20 minutes at room temperature. After washing thrice with PBS, cells were permeabilized with 0.2% Triton X-100 for 15 minutes. After rinsing with PBS, cells were stained with 4V,6-diamidino-2-phenylindole (1 Ag/mL) for 15 minutes. Nuclear condensation and fragmentation was examined under a fluorescence microscope at Â20 magnification. For analysis of cells with sub-G 0 -G 1 DNA content, cells were treated as described above for analysis of cell cycle distribution. Cytoplasmic histone-associated DNA fragmentation was determined as described previously (37) . In some experiments, cells were pretreated with 80 Amol/L pan-caspase inhibitor zVAD-fmk, 40 Amol/L caspase-9-specific inhibitor zLEHD-fmk, or 40 Amol/L caspase-8-specific inhibitor zIETD-fmk for 2 hours before guggulsterone treatment and assessment of apoptosis.
Immunoblotting Control and guggulsterone-treated cells were lysed as described previously (32, 33) . The cell lysate was cleared by centrifugation at 21,000 Â g for 15 minutes, and the supernatant fraction was used for immunoblotting of Bcl-2 family proteins and analysis of caspase cleavage. Proteins were resolved by SDS-PAGE and transferred onto polyvinylidene difluoride membrane. After blocking with 5% nonfat dry milk in TBS containing 0.05% Tween 20, the membrane was incubated with the desired primary antibody for 1 hour at room temperature or for overnight at 4jC. The membrane was then treated with appropriate secondary antibody, and the immunoreactive bands were visualized by enhanced chemiluminescence method. Each membrane was stripped and reprobed with anti-actin antibody to normalize for differences in protein loading.
Results

Guggulsterone Reduced Viability of PC-3 Cells
The effect of guggulsterone on PC-3 cell viability was assessed by sulforhodamine B (Fig. 1B) and trypan blue dye exclusion (Fig. 1C) assays. As can be seen in Fig. 1B , the viability of PC-3 cells was reduced significantly on treatment with guggulsterone in a concentration-dependent manner. For example, a 24-hour treatment of PC-3 cells with 20 and 40 Amol/L guggulsterone caused f40% and 58% reduction in cell viability, respectively, compared with DMSO-treated control (Fig. 1B) . Next, we raised the question of whether guggulsterone-mediated suppression of PC-3 cell growth was selective to cancer cells, which is a highly desirable feature of potential cancer preventive and therapeutic agents. We addressed this question by determining the effect of guggulsterone treatment on viability of a normal prostate epithelial cell line (PrEC). The PrEC cell line has been used extensively as a representative normal prostate epithelial cell line (38 -40) . Proliferating PrEC exhibit features most consistent with the prostate epithelial origin (38) . As can be seen in Fig. 1B (clear columns) , the viability of PrEC was not significantly affected by guggulsterone treatment even at concentrations (e.g., 40 and 80 Amol/L) that were cytotoxic to the PC-3 cell line (Fig. 1B) . Trypan blue dye exclusion assay confirmed that guggulsterone treatment inhibited proliferation of PC-3 cells in a concentration-and time-dependent manner (Fig. 1C) . Collectively, these results indicated that PC-3 cell line, but not a normal prostate epithelial cell line, was sensitive to growth inhibition by guggulsterone.
Guggulsterone Induced Apoptosis in PC-3 Cells To gain insights into the mechanism of guggulsteronemediated suppression of PC-3 cell proliferation, we determined its effect on cell cycle distribution by flow cytometry following staining with propidium iodide. As can be seen in Table 1 , guggulsterone treatment caused a less than impressive increase in G 0 -G 1 -phase cells and a slight reduction in S-phase cells at 20 Amol/L concentration, but the G 2 -M fraction did not differ significantly between control and guggulsterone-treated PC-3 cultures. As shown in Fig. 2A , the guggulsterone-treated PC-3 cultures revealed appearance of cells with subdiploid DNA content, which is a characteristic feature of cells undergoing apoptosis. Apoptosis induction by guggulsterone was confirmed by analysis of cytoplasmic histone-associated DNA fragmentation using an ELISA kit, and the results are shown in Fig. 2B . The PrEC cells were included in the analysis for direct comparison. Treatment of PC-3 cells with guggulsterone resulted in a concentration-dependent and statistically significant increase in cytoplasmic histoneassociated DNA fragmentation compared with control (Fig. 2B ). For instance, the cytoplasmic histone-associated DNA fragmentation was increased by f1.9-fold on a 24-hour treatment of PC-3 cells with 20 Amol/L guggulsterone compared with DMSO-treated control (Fig. 2B , shaded columns). Consistent with the results of cell survival assays, guggulsterone treatment failed to cause DNA fragmentation in PrEC cells (Fig. 2B, clear columns) . Collectively, these results indicated that guggulsterone-mediated inhibition of PC-3 cell proliferation was due to apoptosis induction.
Effect of Guggulsterone Treatment on Levels of Bcl-2 Family Proteins
The Bcl-2 family proteins play critical roles in regulation of apoptosis by functioning as either promoters (e.g., Bax and Bak) or inhibitors (e.g., Bcl-2 and Bcl-xL) of the cell death process (41 -43) . To gain insights into the mechanism of apoptosis induction in our model, we determined the effect of guggulsterone treatment on levels of Bcl-2 family proteins by immunoblotting, and the results are shown in Fig. 3 . The guggulsterone treatment caused a rapid and marked increase in the level of Bax protein. The guggulsterone-mediated induction of Bax protein expression was evident as early as 2 hours after treatment and persisted for the duration of the experiment (24 hours after treatment). The guggulsterone treatment also caused an increase in the protein level of Bak that peaked between 8 and 12 hours and declined thereafter. Similarly, the levels of antiapoptotic proteins Bcl-xL and Bcl-2 were initially increased after treatment with guggulsterone (2 -12 hours) but declined below control level at 16-and 24-hour time points (Fig. 3) . These results suggested that guggulsterone-induced cell death might be regulated by Bcl-2 family proteins.
Effect of Bcl-2 Overexpression on GuggulsteroneInduced Apoptosis
To further examine the role of Bcl-2 in regulation of guggulsterone-induced cell death, we compared sensitivities of PC-3 cells stably transfected with Bcl-2 (PC-3/Bcl-2) and empty vector (PC-3/neo) to apoptosis induction by guggulsterone. As can be seen in Fig. 4A , the level of Bcl-2 protein was f15-fold higher in PC-3/Bcl-2 cells compared with PC-3/neo. Next, we determined the effect of Bcl-2 overexpression on guggulsterone-induced cell death by 4V,6-diamidino-2-phenylindole assay, and the results are shown in Fig. 4B . A 24-hour treatment with 20 Amol/L guggulsterone caused a statistically significant increase in fraction of apoptotic cells with condensed and fragmented DNA in both vector-transfected control and Bcl-2-overexpressing PC-3 cells (Fig. 4B ). In agreement with these results, guggulsterone treatment caused a dose-dependent and statistically significant increase in cytoplasmic histoneassociated DNA fragmentation not only in PC-3/neo cells but also in PC-3 cells stably transfected with Bcl-2 (Fig. 4C) . Collectively, these results indicated that apoptosis induction by guggulsterone was not regulated by Bcl-2.
Bak-Bax Double Knockout MEFs Were Resistant to Guggulsterone-Induced Apoptosis
Because guggulsterone treatment caused a marked increase in the protein levels of Bax and Bak (Fig. 3) , we determined their roles in guggulsterone-induced cell death using SV40 immortalized MEFs derived from WT and Bax and/or Bak knockout mice. As can be seen in Fig. 5A , the MEFs derived from Bax or Bak single knockout mice were relatively less sensitive to growth inhibition by guggulsterone compared with the MEFs derived from WT mice as judged by sulforhodamine B assay, although the differences in cell survival between WT and Bax or Bak single knockout MEFs did not reach statistical significance. On the other hand, the MEFs derived from Bax-Bak double knockout mice were statistically significantly more resistant to cell killing by guggulsterone compared with WT MEFs. For instance, the viability of WT MEFs was reduced by f56% on a 24-hour treatment with 40 Amol/L guggulsterone. A similar treatment with guggulsterone caused a reduction of only f20% in viability of double knockout MEFs (Fig. 5A) .
Consistent with these results, the double knockout MEFs were significantly more resistant to guggulsterone-induced cytoplasmic histone-associated DNA fragmentation compared with the MEFs derived from WT mice (Fig. 5B) . For instance, relative to DMSO-treated control, the cytoplasmic histone-associated DNA fragmentation in WT MEFs was increased byf2.4-fold on a 24-hour treatment with 20 Amol/L guggulsterone. On the other hand, a similar treatment with guggulsterone caused an increase of only f10% in DNA fragmentation over DMSO-treated control in the MEFs derived from Bax-Bak double knockout mice (Fig. 5B) .
Involvement of Caspases in Guggulsterone-Induced Apoptosis
Caspases are aspartate-specific cysteine proteases that play critical roles in execution of apoptosis program (44, 45) . Activation of caspases results in cleavage and inactivation of key cellular proteins (44, 45) . Next, we explored the possibility of whether the guggulsteroneinduced cell death was mediated by caspases. As can be seen in Fig. 6A , treatment of PC-3 cells with 20 Amol/L guggulsterone resulted in cleavage of procaspase-9 that was evidenced by appearance of 37-kDa cleaved intermediate. In addition, guggulsterone treatment caused a decrease in the level of procaspase-8 (this antibody did not recognize cleaved intermediates even after overnight exposure). Immunoblotting using an antibody specific for detection of 19-kDa cleaved caspase-3 intermediate revealed cleavage of procaspase-3 following treatment with guggulsterone for 12 to 24 hours (Fig. 6A) . We used pharmacologic inhibitors of caspases to confirm their involvement in guggulsterone-induced apoptosis. As shown in Fig. 6B , the guggulsterone-induced cytoplasmic histone-associated DNA fragmentation was attenuated in the presence of pan-caspase inhibitor zVAD-fmk and specific inhibitors of caspase-9 (zLEHD-fmk) and caspase-8 (zIETD-fmk). These results pointed toward involvement of both caspase-8 and caspase-9 pathways in execution of guggulsterone-induced apoptosis.
Discussion
Our interest in guggulsterone stemmed from a recent study showing its efficacy against NF-nB activation in different tumor cells (15) . Furthermore, guggulsterone treatment suppressed DNA binding of NF-nB induced by tumor necrosis factor, phorbol ester, cigarette smoke condensate, hydrogen peroxide, and interleukin-1 (15) . Because guggulsterone treatment also suppressed expression of gene products involved in regulation of cell death, including XIAP, Bcl-2, and cFLIP (15), we reasoned that this phytochemical, which has been used extensively in Indian Figure 6 . A, immunoblotting for caspase-9 (full-length and cleaved intermediate), caspase-8 (full-length), and cleaved caspase-3 using lysates from PC-3 cells treated with 20 Amol/L guggulsterone for the indicated time periods. The blots were stripped and reprobed with anti-actin antibody to ensure equal protein loading. Immunoblotting for each protein was done at least twice using independently prepared lysates, and the results were comparable. B, effect of general caspase inhibitor zVAD-fmk, caspase-8-specific inhibitor zIETD-fmk, and casapase-9-specific inhibitor zLEHD-fmk on guggulsterone-induced cytoplasmic histone-associated DNA fragmentation. PC-3 cells were pretreated for 2 h with desired caspase inhibitor and then exposed to 40 Amol/L guggulsterone for 24 h in the presence of the inhibitor. Columns, mean of three determinations; bars, SE. a, P < 0.05, significantly different compared with DMSOtreated control (one-way ANOVA followed by Bonferroni's test for multiple comparisons); b, P < 0.05, significantly different compared with guggulsterone alone treatment group (one-way ANOVA followed by Bonferroni's test for multiple comparisons).
Ayurvedic medicine (7 -11) , might cause apoptotic cell death in tumor cells with constitutively active NF-nB, such as PC-3 human prostate cancer cells. Indeed, the present study indicates that guggulsterone suppresses proliferation of PC-3 cell by causing apoptosis that is characterized by appearance of subdiploid cells, cytoplasmic histone-associated DNA fragmentation, and cleavage of executioner caspase-3. On the other hand, a normal prostate epithelial cell line (PrEC) seems resistant to growth inhibition and apoptosis induction by guggulsterone even at concentrations that are cytotoxic to the PC-3 cells. Although further studies are needed to elucidate the mechanism of differential response of normal and cancer cells to guggulsterone, selectivity toward cancer cells warrants further preclinical and clinical evaluation of guggulsterone for its efficacy against prostate cancer.
Another objective of the present study was to gain insights into the mechanism of apoptosis induction by guggulsterone. The Bcl-2 family proteins have emerged as critical regulators of the mitochondria-mediated apoptosis by functioning as either promoters (e.g., Bax and Bak) or inhibitors (e.g., Bcl-2 and Bcl-xL) of the cell death process (41 -43) . Differential interaction among Bcl-2 protein family members as well as their association with other cellular proteins regulates cell death (41 -43) . For example, Bcl-2 normally blocks apoptosis by forming heterodimer complex with proapoptotic proteins, such as Bax (42, 43, 46, 47) . Mutations in Bak and Bax genes have been shown to cause resistance to apoptosis induction by certain stimuli (48 -50) . The present study reveals that guggulsterone treatment causes a marked increase in the levels of Bax and Bak protein. It is interesting to note, however, that the Bax or Bak single knockout MEFs are only slightly more resistant to guggulsterone-induced cell death compared with the WT MEFs. On the other hand, the MEFs derived from BakBax double knockout mice are significantly more resistant to cell death caused by guggulsterone in comparison with WT MEFs. It is interesting to note that Bcl-2 overexpression fails to offer protection against guggulsterone-induced apoptosis. Thus, it seems reasonable to conclude that multidomain proapoptotic Bcl-2 family members Bax and Bak play an important role in execution of guggulsteroneinduced cell death.
Caspase activation leads to cleavage and inactivation of key cellular proteins, such as poly(ADP-ribose) polymerase (44, 45) . The guggulsterone treatment causes cleavage of caspase-3 that coincides with cleavage of caspase-9 and caspase-8. Caspase-3 is an executioner caspase that can be activated by a mitochondrial pathway involving caspase-9 or a death receptor pathway involving caspase-8 (44, 45) . The results of the present study indicate that guggulsterone-induced apoptosis in PC-3 cells is probably mediated by both caspase-9 and caspase-8 because specific inhibitors of these caspases are able to significantly inhibit the cell death caused by guggulsterone. Involvement of both caspase-9 and caspase-8 pathways in apoptosis induction has also been suggested in other systems (33, 37).
In conclusion, the results of the present study indicate that guggulsterone inhibits proliferation of PC-3 cells in culture by causing apoptosis, whereas a normal prostate epithelial cell line is resistant to growth inhibition and apoptosis induction by this phytochemical. In addition, we provide experimental evidence to implicate Bak and Bax in regulation of guggulsterone-induced apoptosis. These observations provide rationale for further preclinical and clinical evaluation of guggulsterone for its efficacy against prostate cancer.
